Fulcrum Therapeutics FULC
NASDAQ FULC
$3.68 -0.02 (-0.54%)
At close: Oct 1, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Cash from Financing Activities (2018 - 2026)

Updated

Fulcrum Therapeutics' Cash from Financing Activities was $356,000 in Q2 2026, up 18.3% from $301,000 a year earlier.

Analysis

Fulcrum Therapeutics (FULC) Cash from Financing Activities (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Fulcrum Therapeutics' Cash from Financing Activities was $168.41 million through Jun 30, 2026; for FY2025, it was $168.67 million.

  • Cash from Financing Activities shows a five-year compound annual growth rate of 18.8% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $2.75 million in FY2024 (-97.7%), $118.12 million in FY2023 (+40.1%), $84.32 million in FY2022 (-54.8%) and $186.51 million in FY2021 (+162.2%).
  • Quarterly Cash from Financing Activities has moved between -$312,000 (Q1 2026) and $168.3 million (Q4 2025) over five years.
  • Compared with a year earlier, Cash from Financing Activities was higher in 1 of the last four quarters, with an average decline of 40.7%.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q2 2024 (growth of 165.5%); the worst was Q1 2022 (a decline of 99.3%).
  • Per Business Quant data, FULC's Cash from Financing Activities in the three quarters before Q2 2026 was -$312,000 (Q1 2026), $168.3 million (Q4 2025) and $64,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Fulcrum Therapeutics 282.26 Mn 282.26 Mn - 356,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 356,000.00
Mar 31, 2026 -312,000.00
Dec 31, 2025 168.30 Mn
Sep 30, 2025 64,000.00
Jun 30, 2025 301,000.00
Dec 31, 2024 83,000.00
Sep 30, 2024 635,000.00
Jun 30, 2024 377,000.00
Mar 31, 2024 1.65 Mn
Dec 31, 2023 287,000.00
Jun 30, 2023 142,000.00
Mar 31, 2023 117.69 Mn
Dec 31, 2022 218,000.00
Sep 30, 2022 80.95 Mn
Jun 30, 2022 2.81 Mn
Mar 31, 2022 348,000.00
Dec 31, 2021 891,000.00
Sep 30, 2021 137.90 Mn
Jun 30, 2021 209,000.00
Mar 31, 2021 47.50 Mn
API Access

Fulcrum Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=FULC&period=max&api_key=YOUR_API_KEY